Clinical trial
Pilot Medical Evaluation of the T50 Calcification Inhibition Test in NephroCare Clinics
NCT03292029 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Medical Evaluation of the T50 Calcification Inhibition Test in NephroCare Clinics
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 22, 2017
- Completion date
- March 4, 2020
- Enrollment
- 776 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, renal failure, vascular calcification